findmyKOL

Samir Kapadia, MD

Enriched profile

Chairman, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University · Cleveland Clinic

ORCIDNPI
Region🇺🇸 Cleveland, OH · Midwest · United StatesSpecialtyCardiovascular DiseaseFocusAtrial Fibrillation+1
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Samir Kapadia is Chairman, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University at Cleveland Clinic. OpenAlex indexes 1,865 publications with 80,571 citations (h-index 116); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory. Clarivate lists Samir Kapadia as a Highly Cited Researcher (Clinical Medicine, 2020, 2022-2024).

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Samir Kapadia, MD, is Chairman, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic. The public record shows 1,865 publications with 80,571 citations (h-index 116), centered on Atrial Fibrillation, Heart Failure. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 13 companies.

  • Most recent indexed publication: 2026 · European heart journal
  • Top research focus: Atrial Fibrillation
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 13 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Mitral Valve Insufficiency6 trialsHeart Failure3 trialsAortic Valve Stenosis3 trialsConstriction, Pathologic3 trialsAtrial Fibrillation2 trialsStroke1 trialCardiovascular Diseases1 trialVascular Diseases1 trialHeart Valve Diseases1 trialCardiomyopathy, Dilated1 trialThrombosis1 trial

Research focus

OpenAlex concept fingerprint
Atrial FibrillationHeart Failure

Drugs & molecules

across trials, industry payments and publications
Kerendiageneric · FinerenoneClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Boston Scientific CorporationClinical trials1Industry payments14Cardiac Dimensions, Inc.Clinical trials1Industry payments2Siemens Medical Solutions USA, Inc.Clinical trialsIndustry payments14

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,865publications

Distinct works indexed by OpenAlex, matched via ORCID; 126 in PubMed.

80,571citations

Total citations across indexed works.

116h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials
13companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

13 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    58.8%
    Statin14.9%
    Atorvastatin Calcium70%Rosuvastatin Calcium30%
    Part D<11 patients
    Beta blocker12.4%
    Metoprolol Succinate100%
    Part D20 patients
  • Blood & clotting

    26.7%
    P2Y12 inhibitor13.7%
    Clopidogrel100%
    Part D22 patients
    Factor Xa inhibitor13.1%
    Eliquis100%
    Part D18 patients
  • Metabolism & gastrointestinal

    12.2%
    SGLT2 inhibitor12.2%
    Jardiance100%
    Part D17 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/samir-kapadia-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/samir-kapadia-bb6b51235

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Samir-Kapadia-2

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/C5QqPJDOzg4

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • LinkedIn

    linkedin.com/posts/cleveland-clinic-innovations_samir-kapadia-md-speaks-with-cardiac-interventions-activity-7168350763797168128-gUvP

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • Other

    citoday.com/articles/2024-jan-feb/an-interview-with-samir-r-kapadia-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →citoday.com
7 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director

    Sones Cardiac Catheterization Laboratories, Cleveland Clinic

    2019
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newsroom.clevelandclinic.org
  • Chief/Editor

    Textbook of Interventional Cardiology: A Global Perspective (2017) and a Cardiology Board Review book

    2017
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →newsroom.clevelandclinic.org
  • Associate Editor

    JACC: Cardiovascular Interventions

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsroom.clevelandclinic.org
1 more role behind the reveal.Reveal →

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Clinical Medicine
    2020202220232024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Professor of Medicine

    Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsroom.clevelandclinic.org

Media & interviews

press, podcasts and appearances
2 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.